PRP vs Minoxidil, Finasteride, and Transplant Surgery
How does PRP compare with minoxidil, finasteride, and hair transplant surgery?
You're not choosing a winner here, and anyone who frames it that way is selling you something. These four act at completely different points in the same disease, so the useful question isn't which one is best but which part of your problem each one can actually reach. Get that straight and the decision tree gets short.
- Minoxidil: Topical vasodilator that extends anagen and thickens shafts you still have.
- Finasteride: Oral DHT blocker cutting scalp DHT roughly sixty to seventy percent.
- PRP: Injected growth factors that improve blood supply around surviving follicles.
- Transplant surgery: The only option that relocates DHT-resistant follicles into bald scalp.
Minoxidil, finasteride, and PRP all act on follicles that still exist, so hair transplant surgery is the only one of the four that can create coverage on scalp where the follicular units are already gone.
What mechanism of action separates platelet-rich plasma from topical minoxidil?
Think of it as pharmacology versus biological signaling. Minoxidil is a prodrug, which means your scalp has to convert it with an enzyme called sulfotransferase before it does anything at all, and that single conversion step is why plenty of people rub it in correctly for a year and see nothing. PRP skips that question entirely by putting the signal where it needs to be.
| Criteria | Topical Minoxidil | Platelet-Rich Plasma |
|---|---|---|
| What it is | Prodrug needing scalp sulfotransferase | Your own concentrated platelet growth factors |
| Main action | Opens potassium channels, extends anagen | PDGF, VEGF and IGF-1 signaling, new capillary loops |
| Delivery | Across the stratum corneum, daily | Injected to follicular depth in clinic |
| Who responds | Roughly thirty to forty percent | Varies with prep and injection mapping |
Minoxidil only helps the roughly thirty to forty percent of people whose scalp converts it into minoxidil sulfate, while PRP bypasses absorption completely by depositing growth factors at follicular depth.
How does finasteride's hormonal pathway differ from a growth factor injection?
Finasteride goes after the cause. A growth factor injection supports the casualty. That difference in target explains almost everything else about how the two behave, including what happens on the day you stop.
| Criteria | Finasteride | PRP Injection |
|---|---|---|
| Target | 5-alpha reductase type II | The environment around surviving follicles |
| Reach | Systemic, so the whole scalp | Only where the needle actually went |
| What it promises | Stabilization, modest regrowth on top | Density gain over three to six months |
| When you stop | DHT rebounds in weeks, hair lost over six to twelve months | Follicles resume their programmed decline |
Finasteride drops DHT by around seventy percent at the standard one milligram daily dose and works upstream on the disease itself, while PRP makes no claim on androgen metabolism and helps only inside the treated field.
Which treatment produces the largest measured increase in hair density?
Be suspicious of any clean ranking here, because these four were never measured against each other under the same conditions. Standardized trials count terminal hairs per square centimeter in a fixed target area, and the anchors below come from very different quality of evidence. A big number from a twenty-patient six-month study doesn't carry the same weight as a multi-thousand-patient trial, however good it looks in a brochure.
Surgery produces the largest and most certain density change of the four, because placing around thirty follicular units per square centimeter is a mechanical result rather than a biological response you might not have.
When is hair transplant surgery the only option likely to restore coverage?
There's a hard biological line running through this entire comparison, and it's whether a living follicle is still there. Drugs and injections can rescue a struggling follicle, but none of them can build a new one. Which side of that line you're on is something a clinician reads off your scalp, not something you guess from a mirror.
Trichoscopy at twenty to seventy times magnification settles the question, since hair diameter diversity above twenty percent means active miniaturization worth treating, while absent follicular openings mean surgical territory.
What does each treatment cost over a five year horizon?
Run the arithmetic over five years instead of per unit and the ranking most people assume flips over. The scary one-time number is often the contained one, and the modest per-session price is the one that quietly compounds. None of this is usually covered by insurance, since pattern loss is generally classed as cosmetic, so every figure below comes out of your pocket.
PRP quietly carries the largest five year total, since thirteen sessions at a commonly quoted eight hundred dollar midpoint runs about ten thousand four hundred dollars, while a two thousand graft surgery is a single outlay that never renews.
How do the side effect profiles of the four treatments compare?
Risk isn't one scale here, and knowing you tolerate one of these tells you nothing about the next. They fail in categorically different ways, and only one of them fails permanently. That last point should weigh more heavily in your thinking than it usually does.
- Minoxidil: Local irritation, flaking, and unwanted facial hair where the solution migrates.
- Finasteride: Sexual side effects in roughly one to two percent above placebo; contraindicated in pregnancy.
- PRP: Procedural only, so soreness, bruising, and forehead swelling for a few days.
- Surgery: Scarring, shock loss, and hairline design errors that healing never undoes.
Early shedding after starting minoxidil, finasteride, or PRP is synchronized telogen release rather than harm, and quitting at week eight because of it is the most common self-inflicted failure in this field.
Can these treatments be combined, and does combining them improve results?
Combination is the default in serious practice, and the reason is mechanical rather than commercial. Each of the four acts at a point the others don't touch, so the benefits stack instead of overlapping. Sequence matters, because starting everything at once tells you nothing about what's actually working for you.
- Establish the blockade: Start the oral DHT blocker first so the underlying driver is suppressed before anything else is layered on.
- Add the topical: Bring in minoxidil once you're stable, giving the surviving follicles a longer growth phase to work with.
- Run an induction course: Three to four PRP sessions four to six weeks apart, once that medical baseline is already in place.
- Consider surgery last: Wait roughly a year, so the real trajectory of your loss is visible rather than guessed at.
A patient who gets grafts and then drops medical maintenance watches the native hair between the grafts keep thinning, which produces the patchy island look that makes a technically good transplant look obviously artificial.
What ongoing commitment does each treatment require to hold its result?
Permanence is the axis these four separate on most sharply, and it's the one people underweight at the consultation then discover three years later. Only one of the four keeps paying you after you stop paying it.
Stopping finasteride costs you the hair it preserved within six to twelve months, which is why adherence rather than efficacy decides most five year outcomes and why photographs plus trichoscopy every six to twelve months are worth the appointment.
Which patients are poor candidates for each of these options?
Every one of these has a population it will fail, and spotting that population early is most of what a good consultation is for. Treating the wrong disease for a year is the most expensive mistake available to you here. Read the branch below that fits your situation.
Pattern hair loss has to be confirmed before any of the four is started, because telogen effluvium, iron deficiency, thyroid disease, alopecia areata, and scarring alopecias all present as thinning and none of them respond to an androgenetic plan.
